Institutional Ownership Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS). We have compiled data on the 102 institutions that hold shares in the stock, with a total of 53.5 Million shares, which have been reported (via 13F filing form) to have a value of $55.2 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bml Capital Management, LLC
Zionsville, IN |
Apr 23, 2024 Q1 2024 |
9,395,934
shares
|
$9.68 Million
7.8% of portfolio
|
Q1 2024
Added 1338.65%
|
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
5,202,147
shares
|
$5.36 Million
0.0% of portfolio
|
Q1 2024
Reduced 11.92%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
4,929,775
shares
|
$5.08 Million
0.0% of portfolio
|
Q1 2024
Added 4.39%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2024 Q1 2024 |
3,282,982
shares
|
$3.38 Million
0.0% of portfolio
|
Q1 2024
Added 69.31%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
3,273,492
shares
|
$3.37 Million
0.0% of portfolio
|
Q1 2024
Reduced 5.92%
|
|
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
May 15, 2024 Q1 2024 |
3,000,000
shares
|
$3.09 Million
0.56% of portfolio
|
Q1 2024
Reduced 14.29%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2024 Q1 2024 |
2,753,495
shares
|
$2.84 Million
0.09% of portfolio
|
Q1 2024
Reduced 8.17%
|
|
|
Acadian Asset Management LLC
Boston, MA |
May 10, 2024 Q1 2024 |
2,135,367
shares
|
$2.2 Million
0.01% of portfolio
|
Q1 2024
Reduced 9.19%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
1,673,400
shares
|
$1.72 Million
0.0% of portfolio
|
Q1 2024
Reduced 4.18%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
1,565,054
shares
|
$1.61 Million
0.0% of portfolio
|
Q1 2024
Added 12.31%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2024 Q1 2024 |
1,451,100
shares
|
$1.49 Million
0.0% of portfolio
|
Q1 2024
Added 2.12%
|
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
1,338,439
shares
|
$1.38 Million
0.0% of portfolio
|
Q1 2024
Reduced 3.6%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2024 Q1 2024 |
1,329,616
shares
|
$1.37 Million
0.0% of portfolio
|
Q1 2024
Reduced 9.15%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 14, 2024 Q1 2024 |
1,212,260
shares
|
$1.25 Million
0.0% of portfolio
|
Q1 2024
Reduced 27.84%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 15, 2024 Q1 2024 |
957,021
shares
|
$985,731
0.0% of portfolio
|
Q1 2024
Added 2.46%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
930,003
shares
|
$957,903
0.0% of portfolio
|
Q1 2024
Reduced 82.74%
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
May 15, 2024 Q1 2024 |
696,171
shares
|
$717,056
0.27% of portfolio
|
Q1 2023
New holding
|
|
|
Gsa Capital Partners LLP
London, X0 |
May 03, 2024 Q1 2024 |
679,137
shares
|
$699,511
0.07% of portfolio
|
Q1 2024
Reduced 57.23%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
May 15, 2024 Q1 2024 |
612,205
shares
|
$630,571
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
May 15, 2024 Q1 2024 |
569,832
shares
|
$586,926
0.08% of portfolio
|
Q1 2024
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
562,224
shares
|
$579,090
0.0% of portfolio
|
Q1 2024
Reduced 14.77%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
491,666
shares
|
$506,415
0.0% of portfolio
|
Q1 2024
Reduced 49.62%
|
|
|
Acuitas Investments, LLC
|
May 10, 2024 Q1 2024 |
461,663
shares
|
$475,512
0.3% of portfolio
|
Q1 2024
New holding
|
|
|
Aisling Capital Management LP
New York, NY |
May 14, 2024 Q1 2024 |
434,455
shares
|
$447,488
0.18% of portfolio
|
Q4 2022
Reduced 31.52%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 08, 2024 Q1 2024 |
419,334
shares
|
$431,914
0.0% of portfolio
|
Q1 2024
Reduced 3.9%
|
|